Your browser doesn't support javascript.
loading
Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit.
Kong, Yee Wen; Venkatesh, Nisha; Paldus, Barbora; Lee, Melissa H; Zhu, Jasmine J; Sawyer, Matthew; Chakrabarti, Anindita; Uren, Christopher; MacIsaac, Richard J; Jenkins, Alicia J; O'Neal, David N.
Afiliación
  • Kong YW; Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
  • Venkatesh N; Department of Medicine, University of Melbourne, Fitzroy, Australia.
  • Paldus B; Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
  • Lee MH; Department of Medicine, University of Melbourne, Fitzroy, Australia.
  • Zhu JJ; Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
  • Sawyer M; Department of Medicine, University of Melbourne, Fitzroy, Australia.
  • Chakrabarti A; Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
  • Uren C; Department of Medicine, University of Melbourne, Fitzroy, Australia.
  • MacIsaac RJ; Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
  • Jenkins AJ; Department of Medicine, University of Melbourne, Fitzroy, Australia.
  • O'Neal DN; Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
Diabetes Technol Ther ; 24(7): 531-534, 2022 07.
Article en En | MEDLINE | ID: mdl-35167376
ABSTRACT
Devices have facilitated improvement in glycemia in individuals with type 1 diabetes mellitus (T1DM), but self-management remains key. It is unclear whether people review their device data before clinic appointment. We assessed this by a survey. T1DM adults using glucose sensors and/or insulin pumps attending an Australian public hospital (diabetes clinics >4 months) were prospectively surveyed. The percentage who uploaded and reviewed their data was determined and their interest in education facilitating understanding of their device data was assessed. Of 138 adults (100% participation rate), 79% uploaded and 32% reviewed their device data before their clinic appointments. Individuals using pumps with sensors were most likely to review their data. Median HbA1c levels were lower in those who did versus did not review their device data (50.8 vs. 61.8 mmol/mol, P = 0.0001). Most (89%) were interested in education. Although diabetes technology has improved glycemia in T1DM, the benefits may be maximized through device-specific education programs enhancing self-management.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Insulinas Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Insulinas Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Australia